跳到正文
登录

公司

Altruist Biologics

打开结构图

简介

总部
CN

Altruist Biologics 的结构

Altruist Biologics

公司

4 个关联
归属投资与持股
自有产品与技术
下游客户
关系出现时间2026
Altruist Biologics公司 · 4 个关联
第 1 层

下游客户2

归属投资与持股1

自有产品与技术1

在关系网络中的位置

第 49934 位,共 118934 个前 42%本周下降 31100 位

2 条直接关系

按有证据的公开关系计算,每天更新。

关系

公司之间的资金

谁投资、持有、收购或为谁融资,来自 AiSeek 有证据的关系。

Innovent拥有Altruist Biolog…

流入Altruist Biologics

线只表示这条关系存在以及方向,粗细不代表金额;圆点移动只是为了指示方向。

箭头表示关系方向,可按业务类别筛选。

  • Altruist Biologics属于 →Innovent
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-29 23:00
      Altruist Biologics, a world-class contract development and manufacturing organization (CDMO) and wholly owned subsidiary of Innovent Biologics (1801.HK)
      查看来源
    • 公司披露PR Newswire news releases2026-10-29 23:00
      Altruist Biologics is a reliable CDMO service provider and wholly owned subsidiary of Innovent Biologics, Inc. (1801.HK)
      查看来源
    • 公司披露PR Newswire news releases2026-10-29 23:00
      Altruist Biologics is a reliable CDMO service provider and wholly owned subsidiary of Innovent Biologics, Inc. (1801.HK)
      查看来源
  • Altruist Biologics经营于 →Suzhou
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-29 23:00
      The company operates advanced cGMP facilities in Suzhou and Hangzhou, China
      查看来源
  • Altruist Biologics经营于 →Hangzhou
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-29 23:00
      The company operates advanced cGMP facilities in Suzhou and Hangzhou, China
      查看来源
  • Innovent拥有 →Altruist Biologics
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-29 23:00
      Altruist Biologics, a world-class contract development and manufacturing organization (CDMO) and wholly owned subsidiary of Innovent Biologics (1801.HK)
      查看来源
  • Altruist Biologics制造 →Bioconjugates
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-29 23:00
      The site also offers a standalone ADC and AXC bioconjugation facility to support the manufacture of various bioconjugates
      查看来源

显示第 1 至 5 条,共 5 条

结论

结合来源阅读结论,展开条目查看证据。

事实证据 3
属于Innovent

Altruist Biologics, a world-class contract development and manufacturing organization (CDMO) and wholly owned subsidiary of Innovent Biologics (1801.HK)

PR Newswire news releases · 2026-10-29 23:00

查看证据
  • 公司披露PR Newswire news releases2026-10-29 23:00
    Altruist Biologics, a world-class contract development and manufacturing organization (CDMO) and wholly owned subsidiary of Innovent Biologics (1801.HK)
    查看来源
  • 公司披露PR Newswire news releases2026-10-29 23:00
    Altruist Biologics is a reliable CDMO service provider and wholly owned subsidiary of Innovent Biologics, Inc. (1801.HK)
    查看来源
  • 公司披露PR Newswire news releases2026-10-29 23:00
    Altruist Biologics is a reliable CDMO service provider and wholly owned subsidiary of Innovent Biologics, Inc. (1801.HK)
    查看来源
事实证据 2
total production capacity232,000 liters

with a total production capacity of 232,000 liters

PR Newswire news releases · 2026-10-29 23:00

查看证据
  • 公司披露PR Newswire news releases2026-10-29 23:00
    with a total production capacity of 232,000 liters
    查看来源
  • 公司披露PR Newswire news releases2026-10-29 23:00
    with a total production capacity of 232,000 liters
    查看来源
事实证据 2
commercial batch success rate>99.8 %

with a >99.8% success rate.

PR Newswire news releases · 2026-10-29 23:00

查看证据
  • 公司披露PR Newswire news releases2026-10-29 23:00
    with a >99.8% success rate.
    查看来源
  • 公司披露PR Newswire news releases2026-10-29 23:00
    with a >99.8% success rate
    查看来源
事实证据 1
global regulatory filings100

Its track record includes 100 global regulatory filings

PR Newswire news releases · 2026-10-29 23:00

查看证据
  • 公司披露PR Newswire news releases2026-10-29 23:00
    Its track record includes 100 global regulatory filings
    查看来源
事实证据 1

The site also offers a standalone ADC and AXC bioconjugation facility to support the manufacture of various bioconjugates

PR Newswire news releases · 2026-10-29 23:00

查看证据
  • 公司披露PR Newswire news releases2026-10-29 23:00
    The site also offers a standalone ADC and AXC bioconjugation facility to support the manufacture of various bioconjugates
    查看来源
事实证据 1
拥有Innovent

Altruist Biologics, a world-class contract development and manufacturing organization (CDMO) and wholly owned subsidiary of Innovent Biologics (1801.HK)

PR Newswire news releases · 2026-10-29 23:00

查看证据
  • 公司披露PR Newswire news releases2026-10-29 23:00
    Altruist Biologics, a world-class contract development and manufacturing organization (CDMO) and wholly owned subsidiary of Innovent Biologics (1801.HK)
    查看来源

显示第 1 至 6 条,共 12 条

市场与估值

估值数据需要 Pro 或 Research。

升级到 Pro 解锁

推荐一个值得监测的页面

这家公司有哪些页面值得盯着,比如价格、更新日志、条款或招聘页?推荐给我们。每条推荐都有人看;收录后,这个页面会为所有读者一起监测,并且只有连续两次抓取一致才算一次变化。

登录后推荐页面

暂无: 公司信号 · 财务数据 · 披露文件 · 据点 · 业绩指引